Tachycardia-Induced Cardiomyopathy (TCM)
Definition
Tachycardia-induced cardiomyopathy (TCM), or arrhythmia-induced cardiomyopathy, is a reversible cause of impaired LV function due to persistent tachycardia or very frequent ventricular premature beats. It can lead to HF and death if untreated, but LV function frequently recovers after restoration of a normal heart rate. The incidence is unknown but TCM has been reported across all age groups from foetuses to the elderly. sources/svt-esc-2019 (rating: very high)
Key Concepts
Mechanisms
- Any chronic cardiac arrhythmia can cause TCM; incessant AVRT due to septal APs, rapid AF, idiopathic VT, AT (especially PJRT and focal AT), and persistent ectopic beats are best described sources/svt-esc-2019
- In patients <18 years, focal AT is the commonest cause; PJRT is the classic teaching example
- Rapid pacing in animal models induces: cytoskeletal changes, abnormal calcium cycling, increased catecholamines, decreased beta-1 adrenergic receptor density, oxidative stress, myocardial energy depletion, and ischaemia from increased HR
- Endomyocardial biopsy in TCM shows deranged cardiomyocyte and mitochondrial morphology, and macrophage-dominated cardiac inflammation — distinct from other cardiomyopathies sources/svt-esc-2019
- Why only ≤30% of patients with frequent ventricular ectopics develop TCM is not fully established sources/svt-esc-2019
Diagnosis
- TCM is one of the very few reversible causes of HF and dilated cardiomyopathy — should be considered in any patient with new-onset LV dysfunction
- Consider TCM in any patient with reduced LVEF and sustained HR >100 bpm: Class I/B recommendation sources/svt-esc-2019
- Diagnosis is one of exclusion: other causes of cardiomyopathy excluded AND LV function improves after arrhythmia eradication or rate control
- Typical parameters: LV EF <30%, LVEDD <65 mm, LVESD <50 mm (more dilated volumes suggest underlying dilated cardiomyopathy, though overlap exists)
- Cardiac MRI advisable to exclude intrinsic structural change
- Serial NT-proBNP (ratio at baseline vs follow-up) helps distinguish TCM from irreversible idiopathic dilated cardiomyopathy
- 24-hour (or multi-day) ambulatory ECG monitoring is essential to identify subclinical or intermittent arrhythmias: IIa/B sources/svt-esc-2019
Therapy
- Catheter ablation for TCM due to SVT: Class I/B — first-line treatment when the culprit arrhythmia can be identified and ablated sources/svt-esc-2019
- Beta-blockers (with proven HFrEF mortality benefit): Class I/A — if catheter ablation fails or is not applicable; this is one of the highest-class recommendations (I/A) in the SVT guideline sources/svt-esc-2019
- Consider TCM whenever reduced LVEF + elevated HR >100 bpm: Class I/B sources/svt-esc-2019
- 24h ambulatory ECG monitoring for subclinical arrhythmias: IIa/B sources/svt-esc-2019
- AV nodal ablation + pacing (biventricular or His-bundle): Class I/C — if tachycardia cannot be ablated or controlled by drugs; biventricular or His-bundle pacing preferred over RV pacing to minimize pacing-induced dyssynchrony sources/svt-esc-2019
- Long-term beta-blockers + ACE inhibitors or ARBs before and after successful ablation — for known beneficial effects on LV remodelling
- LV function typically improves after ~3 months of normal heart rate restoration; long-term monitoring for arrhythmia recurrence is recommended
IST as a Special Case
- IST is explicitly stated to NOT be associated with TCM in ESC 2019 — this distinguishes IST from other forms of persistent tachycardia sources/svt-esc-2019
- If TCM develops in an IST patient, beta-blockers are the treatment of choice (as opposed to catheter ablation) sources/svt-esc-2019
Contradictions / Open Questions
- True incidence of TCM is unknown — no prospective epidemiological studies
- Why ≤30% of patients with frequent PVCs develop TCM while the majority do not is unresolved; burden, morphology, and coupling interval all implicated but no definitive predictors established sources/svt-esc-2019
- Minimum arrhythmia burden required to cause TCM not precisely defined; case reports span wide range; >15–20% PVC burden conventionally cited as high-risk threshold but this is based on observational data
- Optimal pacing modality after AV nodal ablation (biventricular vs His-bundle) not established by RCT; His-bundle pacing increasingly preferred in experienced centres sources/svt-esc-2019
Connections
- Related to concepts/SVT-Management — TCM is a Class I indication for catheter ablation in SVT
- Related to concepts/AVRT-Accessory-Pathway — PJRT and incessant septal AVRT are classic TCM causes
- Related to concepts/AVNRT — rare incessant atypical AVNRT can cause TCM
- Related to concepts/Inappropriate-Sinus-Tachycardia — IST explicitly does NOT cause TCM